TNSN92115A1 - Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation - Google Patents
Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisationInfo
- Publication number
- TNSN92115A1 TNSN92115A1 TNTNSN92115A TNSN92115A TNSN92115A1 TN SN92115 A1 TNSN92115 A1 TN SN92115A1 TN TNSN92115 A TNTNSN92115 A TN TNSN92115A TN SN92115 A TNSN92115 A TN SN92115A TN SN92115 A1 TNSN92115 A1 TN SN92115A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- benzimidazoles
- substitutes
- compounds
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9103776A SE9103776D0 (sv) | 1991-12-19 | 1991-12-19 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN92115A1 true TNSN92115A1 (fr) | 1993-06-08 |
Family
ID=20384667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN92115A TNSN92115A1 (fr) | 1991-12-19 | 1992-12-18 | Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0628049A1 (enExample) |
| JP (1) | JPH07502503A (enExample) |
| KR (1) | KR940703840A (enExample) |
| CN (1) | CN1031827C (enExample) |
| AP (1) | AP397A (enExample) |
| AU (1) | AU665043B2 (enExample) |
| CA (1) | CA2124689A1 (enExample) |
| CZ (1) | CZ146794A3 (enExample) |
| FI (1) | FI942912A0 (enExample) |
| HR (1) | HRP921400A2 (enExample) |
| HU (1) | HUT68270A (enExample) |
| IL (1) | IL104025A0 (enExample) |
| IS (2) | IS4079A (enExample) |
| MA (1) | MA22746A1 (enExample) |
| MX (1) | MX9207269A (enExample) |
| NO (1) | NO942230D0 (enExample) |
| NZ (1) | NZ246220A (enExample) |
| SE (1) | SE9103776D0 (enExample) |
| SI (1) | SI9200402A (enExample) |
| SK (1) | SK73594A3 (enExample) |
| TN (1) | TNSN92115A1 (enExample) |
| TW (1) | TW224100B (enExample) |
| WO (1) | WO1993012124A1 (enExample) |
| YU (1) | YU101692A (enExample) |
| ZA (1) | ZA928836B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19645974C1 (de) * | 1996-11-07 | 1998-08-13 | Andreas Johannes Kesel | (Z)-5-[[3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylen]-2-thioxo-4- thiazolidinon, Verfahren zu dessen Herstellung und Verwendung |
| AU754965B2 (en) * | 1997-12-31 | 2002-11-28 | University Of Kansas, The | Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| CA2616512A1 (en) | 2005-07-28 | 2007-02-08 | Intervet International B.V. | Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof |
| TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
| KR101403135B1 (ko) | 2006-06-14 | 2014-06-19 | 인터벳 인터내셔널 비.브이. | 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물 |
| TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
| MX365051B (es) * | 2014-11-26 | 2019-05-09 | Univ Mexico Nac Autonoma | Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ234564A (en) * | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
| SE8801907D0 (sv) * | 1988-05-20 | 1988-05-20 | Haessle Ab | Novel pharmacological compounds |
| SE9002206D0 (sv) * | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
| WO1991019712A1 (en) * | 1990-06-20 | 1991-12-26 | Aktiebolaget Astra | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
-
1991
- 1991-12-19 SE SE9103776A patent/SE9103776D0/xx unknown
-
1992
- 1992-10-06 IS IS4079A patent/IS4079A/is unknown
- 1992-11-11 TW TW081109053A patent/TW224100B/zh active
- 1992-11-16 ZA ZA928836A patent/ZA928836B/xx unknown
- 1992-11-25 YU YU101692A patent/YU101692A/sh unknown
- 1992-12-07 HR HR921400A patent/HRP921400A2/hr not_active Application Discontinuation
- 1992-12-08 SK SK735-94A patent/SK73594A3/sk unknown
- 1992-12-08 KR KR1019940702131A patent/KR940703840A/ko not_active Withdrawn
- 1992-12-08 CZ CZ941467A patent/CZ146794A3/cs unknown
- 1992-12-08 FI FI942912A patent/FI942912A0/fi not_active Application Discontinuation
- 1992-12-08 WO PCT/SE1992/000844 patent/WO1993012124A1/en not_active Ceased
- 1992-12-08 HU HU9401840A patent/HUT68270A/hu unknown
- 1992-12-08 AU AU31752/93A patent/AU665043B2/en not_active Ceased
- 1992-12-08 EP EP93900477A patent/EP0628049A1/en not_active Withdrawn
- 1992-12-08 CA CA002124689A patent/CA2124689A1/en not_active Abandoned
- 1992-12-08 NZ NZ246220A patent/NZ246220A/en unknown
- 1992-12-08 IL IL104025A patent/IL104025A0/xx unknown
- 1992-12-08 JP JP5510832A patent/JPH07502503A/ja active Pending
- 1992-12-14 AP APAP/P/1992/000463A patent/AP397A/en active
- 1992-12-15 MX MX9207269A patent/MX9207269A/es unknown
- 1992-12-16 MA MA23036A patent/MA22746A1/fr unknown
- 1992-12-18 SI SI19929200402A patent/SI9200402A/sl unknown
- 1992-12-18 CN CN92114364A patent/CN1031827C/zh not_active Expired - Fee Related
- 1992-12-18 TN TNTNSN92115A patent/TNSN92115A1/fr unknown
- 1992-12-18 IS IS3960A patent/IS3960A/is unknown
-
1994
- 1994-06-14 NO NO942230A patent/NO942230D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW224100B (enExample) | 1994-05-21 |
| SE9103776D0 (sv) | 1991-12-19 |
| YU101692A (sh) | 1995-10-03 |
| CA2124689A1 (en) | 1993-06-24 |
| AU3175293A (en) | 1993-07-19 |
| CZ146794A3 (en) | 1996-02-14 |
| SI9200402A (en) | 1993-06-30 |
| AU665043B2 (en) | 1995-12-14 |
| HU9401840D0 (en) | 1994-09-28 |
| IS4079A (is) | 1993-06-20 |
| NO942230L (no) | 1994-06-14 |
| FI942912L (fi) | 1994-06-17 |
| FI942912A7 (fi) | 1994-06-17 |
| SK73594A3 (en) | 1995-02-08 |
| HUT68270A (en) | 1995-06-28 |
| IL104025A0 (en) | 1993-05-13 |
| NZ246220A (en) | 1996-02-27 |
| JPH07502503A (ja) | 1995-03-16 |
| MA22746A1 (fr) | 1993-07-01 |
| NO942230D0 (no) | 1994-06-14 |
| WO1993012124A1 (en) | 1993-06-24 |
| CN1073446A (zh) | 1993-06-23 |
| AP9200463A0 (en) | 1993-01-31 |
| HRP921400A2 (en) | 1994-08-31 |
| KR940703840A (ko) | 1994-12-12 |
| AP397A (en) | 1995-08-14 |
| FI942912A0 (fi) | 1994-06-17 |
| EP0628049A1 (en) | 1994-12-14 |
| ZA928836B (en) | 1993-07-05 |
| IS3960A (is) | 1993-06-20 |
| MX9207269A (es) | 1993-06-01 |
| CN1031827C (zh) | 1996-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seltzer et al. | Flare-ups in endodontics: I. Etiological factors | |
| FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
| EP0693924A4 (en) | METHOD FOR IN VIVO ADMINISTRATION OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED THEREFOR | |
| ES2086270T5 (es) | Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos. | |
| UY23665A1 (es) | Procedimiento para la preparacion de compuesto farmaceutico | |
| DE3582439D1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| ATE268605T1 (de) | Pharmazeutische akzeptabel dnase zusammensetzung | |
| FR2512670B1 (fr) | Capsules contenant le principe actif d'un allergene et procede pour leur preparation | |
| RU95109905A (ru) | Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта | |
| MX9605940A (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ID24901A (id) | Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh | |
| UA40589C2 (uk) | Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація | |
| DE69510190D1 (de) | Verwendung von fettsäureester als bioklebstoffe | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| RU94026283A (ru) | Фармацевтическое соединение | |
| ES8609325A1 (es) | Un procedimiento para preparar derivados de guanina | |
| ATE87484T1 (de) | Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| ATA21888A (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken | |
| BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
| JPS62265222A (ja) | 細胞膜の脂質構造および機能の修飾法並びにこれに使用する製剤組成物 | |
| HU911184D0 (en) | Process for the production of medical preparations containing n-alkylized 1,4-dihydropirine-carbonic acid esthers and process for the production of such esthers | |
| ES2167385T3 (es) | Medicamentos de accion antihiperglicemica. | |
| MD545G2 (ro) | Preparat medicamentos | |
| Sinzinger et al. | Prostaglandin 12 reduces activation of human arterial smooth muscle cells in-vivo |